Hyperglycemia Is the Main Mediator of Prediabetes- and Type 2 Diabetes-Associated Impairment of Microvascular Function: The Maastricht Study

Diabetes Care. 2017 Aug;40(8):e103-e105. doi: 10.2337/dc17-0574. Epub 2017 Jun 16.

Ben M Sörensen^{1

2}, Alfons J H M Houben^{1

2}, Tos T J M Berendschot³, Jan S A G Schouten³, Abraham A Kroon^{1

2}, Carla J H van der Kallen^{1

2}, Ronald M A Henry^{1

2

4}, Annemarie Koster^{5

6}, Koen D Reesink^{1

7}, Pieter C Dagnelie^{1

5

8}, Nicolaas C Schaper^{1

2

5}, Casper G Schalkwijk^{1

2}, Miranda T Schram^{1

2

4}, Coen D A Stehouwer^{9

2}

¹ School for Cardiovascular Diseases (CARIM), Maastricht University, Maastricht, the Netherlands.
² Department of Internal Medicine, Maastricht University Medical Center+, Maastricht, the Netherlands.
³ University Clinic for Ophthalmology, Maastricht University Medical Center+, Maastricht, the Netherlands.
⁴ Heart and Vascular Center, Maastricht University Medical Center+, Maastricht, the Netherlands.
⁵ Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, the Netherlands.
⁶ Department of Social Medicine, Maastricht University, Maastricht, the Netherlands.
⁷ Department of Biomedical Engineering, Maastricht University, Maastricht, the Netherlands.
⁸ Department of Epidemiology, Maastricht University, Maastricht, the Netherlands.
⁹ School for Cardiovascular Diseases (CARIM), Maastricht University, Maastricht, the Netherlands cda.stehouwer@mumc.nl.

No abstract available

Publication types